Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

NCT00989274 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Late approval by the Secretariat of Health, and expiration of vaccine

Conditions

Influenza

Interventions

BIOLOGICAL: Vaccine Sanofi A(H1N1) 15 ug & trivalent
BIOLOGICAL: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante
BIOLOGICAL: Vaccine Sanofi A(H1N1) 7.5 ug

Sponsor

Instituto Nacional de Salud Publica, Mexico

Collaborators

[object Object]